Share this post on:

Product Name :
Alendronate Sodium/Colecalciferol

Search keywords :
Alendronate sodium

drugId :
null

Target Vo:
Vitamin D receptor

Target Vo Short Name :
VDR

Moa_Name:
Osteoclasts inhibitors

First Approval Country :
United States

First Approval Date Filter:
2005

Origin Company_Name :
Merck Sharp & Dohme Corp

Active Company_Name :
Merck Sharp & Dohme Ltd

Active Indication_Name:
Osteoporosis

In Active Indication_Name:
Vitamin D Deficiency

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
TBK1 Rabbit mAb site
Nrf1 Rabbit mAb manufacturer
EPOR Antibody: EPOR Antibody is an unconjugated, approximately 56 kDa, rabbit-derived, anti-EPOR polyclonal antibody. EPOR Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, rat, and predicted: mouse, dog, cow, horse background without labeling.

Share this post on:

Author: Interleukin Related